COMMUNIQUÉS West-GlobeNewswire

Dynavax to Present at the William Blair & Co. Annual Growth Stock Conference
03/06/2019
BERKELEY, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), today announced that Ryan Spencer, Senior Vice President, Commercial, and Interim Co-President, will present at the [...]
Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers
03/06/2019
- SRK-015 was well-tolerated in healthy volunteers across all tested doses, supporting evaluation in the ongoing Phase 2 TOPAZ trial in Spinal Muscular Atrophy (SMA) - Pharmacodynamic results from the completed multiple [...]
Sientra Commences Public Offering of Common Stock
03/06/2019
SANTA BARBARA, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that it has commenced an underwritten public follow-on [...]
Oncternal Therapeutics Announces Updated Interim Data from a Phase 1/2 Study of Cirmtuzumab in Combination with Ibrutinib
03/06/2019
Data presented today at the 2019 American Society of Clinical Oncology Annual Meeting SAN DIEGO, June 03, 2019 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc., a clinical-stage biotechnology company focused on [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
03/06/2019
COPENHAGEN, Denmark, June 3, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the share buy-back program, which was announced and initiated on May 22, 2019, has now been terminated, as the intended [...]
CORRECTION -- Strateos combines Transcriptic and 3Scan to become Premier Drug Discovery Technology Partner for the Pharmaceutical Industry
03/06/2019
Industry Leader Mark Fischer-Colbrie appointed as Chief Executive Officer SAN FRANCISCO, June 03, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Strateos, please note that the link [...]
Ontario Pharmacists Association Announces Recipients of Lifetime Achievement and Pharmacist of the Year Awards
03/06/2019
TORONTO, June 03, 2019 (GLOBE NEWSWIRE) -- The Ontario Pharmacists Association (OPA) is pleased to announce that David Windross of Toronto is the recipient of the 2019 Lifetime Achievement Award and John Girgis of [...]
Overall Response Rate of 76% in Advanced Melanoma Patients with Dynavax’s SD-101 in Combination with KEYTRUDA® (pembrolizumab); Data Presented Today at the 2019 ASCO Annual Meeting
03/06/2019
Progression Free Survival (PFS) rate of 18-months in 72% of patients Clinical efficacy in patients with immunologically cold tumor at baseline The combination of SD-101 and pembrolizumab was well-tolerated, consistent [...]
Strateos combines Transcriptic and 3Scan to become Premier Drug Discovery Technology Partner for the Pharmaceutical Industry
03/06/2019
Industry Leader Mark Fischer-Colbrie appointed as Chief Executive Officer SAN FRANCISCO, June 03, 2019 (GLOBE NEWSWIRE) -- The boards of Transcriptic and 3Scan have unanimously approved an agreement to merge companies [...]
SetPoint Medical to Present Results From The U.S. Pilot Study in Rheumatoid Arthritis Patients at European Congress of Rheumatology (EULAR) 2019
03/06/2019
VALENCIA, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results from its U.S. pilot [...]
Ossur Hf : Transactions in relation to share buyback program
03/06/2019
Announcement no. 35/2019 3 June 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share buyback [...]
Axiom Real-Time Metrics is a Proud Sponsor of the Women in Bio Annual Plenary Event Today at the BIO International Convention
03/06/2019
TORONTO, June 03, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is a proud sponsor of the Women in Bio Annual Plenary event in Philadelphia [...]
Nicox: Number of voting rights 31 May 2019
03/06/2019
Nicox SA Société anonyme with a registered capital of € 29,910,120 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On June 3, 2019, MONTHLY PUBLICATION OF THE [...]
Nicox: Droits de vote 31 mai 2019
03/06/2019
Nicox SA Société anonyme au capital de 29 910 120 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 3 juin 2019, PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS [...]
Néovacs annonce avoir réuni son Assemblée Générale Mixte sur seconde convocation le mercredi 29 mai 2019
03/06/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE AVOIR REUNI SON ASSEMBLÉE GÉNÉRALE MIXTE SUR SECONDE CONVOCATION LE MERCREDI 29 MAI 2019, SOUS LA PRÉSIDENCE DE M. JEAN-JACQUES BERTRAND [...]
Kiadis Pharma to present at upcoming conferences in June 2019
03/06/2019
Kiadis Pharma to present at upcoming conferences in June 2019 Amsterdam, The Netherlands, June 3, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a clinical stage [...]
IBA - Transparency notification
03/06/2019
Louvain-la-Neuve, Belgium, June 03, 2019, 17.35 Summary of the notification IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to [...]
IBA - Publication relative à une notification de transparence
03/06/2019
Louvain-la-Neuve, Belgique, 3 juin 2019, 17.35 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir [...]
Total number of shares and voting rights in Zealand Pharma as of May 31, 2019
03/06/2019
Company announcement – No. 18 / 2019 Total number of shares and voting rights in Zealand Pharma as of May 31, 2019 Copenhagen, June 3, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a Copenhagen-based [...]

Pages